Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1107345
rs1107345
IL2RA
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1250550
rs1250550
ZMIZ1
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1323292
rs1323292
LOC105371664
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1364229
rs1364229 		A 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1439112
rs1439112
MGAT5
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1444766
rs1444766
KALRN
G 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1494555
rs1494555
IL7R
0.010 GeneticVariation BEFREE After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma. 20952689

2011
dbSNP: rs16947122
rs16947122
FBXW8
C 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs20541
rs20541
IL13 ; TH2LCRR
0.010 GeneticVariation BEFREE After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma. 20952689

2011
dbSNP: rs2425752
rs2425752
NCOA5
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs2777899
rs2777899
VMP1
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs2922994
rs2922994 		0.710 GeneticVariation BEFREE Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. 25569183

2015
dbSNP: rs2922994
rs2922994 		G 0.710 GeneticVariation GWASCAT Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. 25569183

2015
dbSNP: rs2941509
rs2941509
IKZF3
T 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs344550
rs344550
C3
0.010 GeneticVariation BEFREE Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases. 22170086

2012
dbSNP: rs3804100
rs3804100
TLR2
0.010 GeneticVariation BEFREE We found little evidence of association between TLR2 variation and all NHL, although the rare variant rs3804100 was significantly associated with marginal zone lymphoma (MZL), both overall (OR(CT/CC) 1.89, 95% CI 1.27-2.81; P(dominant) = 0.002) and in two of the three studies. 19029192

2009
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE MYD88 L265P was found in 49/51 (96%) LPL cases and in 1/13 (7·6%) MZL (splenic type), whereas all CLL samples remained negative. 25819228

2015
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. 25723115

2015
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. 22944768

2013
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE Thus, pyrosequencing for the MYD88 L265P mutation demonstrates a high clinical sensitivity and specificity to distinguish LPL from MZL and CLL. 26230596

2015
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE The diagnosis of Waldenström Macroglobulinaemia (WM)/lymphoplasmacytic lymphoma (LPL) remains one of exclusion because other B-cell lymphoproliferative disorders (B-LPD), such as marginal zone lymphoma (MZL), can fulfil similar criteria, including MYD88 L265P mutation. 30198568

2019
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE The most distinguishing features of LPL with respect to MZL were focal paratrabecular involvement (P < .001), the presence of lymphoplasmacytoid cells (P < .001) and Dutcher bodies (P < .001), increased numbers of mast cells (P < .001), and the MYD88 L265P mutation (P < .001). 25972321

2015
dbSNP: rs497309
rs497309
C2 ; CYP21A2
0.010 GeneticVariation BEFREE Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases. 22170086

2012
dbSNP: rs568408
rs568408
IL12A ; IL12A-AS1
0.010 GeneticVariation BEFREE After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma. 20952689

2011
dbSNP: rs6062314
rs6062314
ZBTB46
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019